147 related articles for article (PubMed ID: 12373846)
1. [Progress in diagnosis and therapy for Parkinson's disease].
Mizuno Y
Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2344-8. PubMed ID: 12373846
[No Abstract] [Full Text] [Related]
2. [Genetics of Parkinson's disease].
García de Yébenes J
Neurologia; 2001 Jan; 16(1):1-6. PubMed ID: 11234656
[No Abstract] [Full Text] [Related]
3. [Etiology and physiopathology of patients with parkinson's disease].
Ogawa N
Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1394-9. PubMed ID: 13677885
[No Abstract] [Full Text] [Related]
4. Tau and Parkinson disease.
Spillantini MG; Goedert M
JAMA; 2001 Nov; 286(18):2324-6. PubMed ID: 11710900
[No Abstract] [Full Text] [Related]
5. Genetics of Parkinson's disease.
Polymeropoulos MH
Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
[TBL] [Abstract][Full Text] [Related]
6. [Molecular pathogenesis of familial Parkinson's disease].
Kitada T; Mizuno Y
Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
[TBL] [Abstract][Full Text] [Related]
7. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Parkinson's disease with multiple drugs].
Kuno S
Nihon Rinsho; 1997 Jan; 55(1):59-64. PubMed ID: 9014424
[TBL] [Abstract][Full Text] [Related]
9. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
10. [Heterogeneity of Parkinson's disease].
Vidailhet M
Bull Acad Natl Med; 2003; 187(2):259-75; discussion 275-6. PubMed ID: 14556440
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
Burke RE
Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
[No Abstract] [Full Text] [Related]
12. [Studies on pathogenesis of Parkinson's disease].
Mizuno Y
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():66-70. PubMed ID: 15796059
[No Abstract] [Full Text] [Related]
13. Etiology of Parkinson's disease: Genetics and environment revisited.
Steece-Collier K; Maries E; Kordower JH
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13972-4. PubMed ID: 12391311
[No Abstract] [Full Text] [Related]
14. [A 73-year-old woman with familial Parkinson's disease].
Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of parkinsonism].
Ghika J
Rev Med Suisse Romande; 2000 Sep; 120(9):733-8. PubMed ID: 11094538
[No Abstract] [Full Text] [Related]
16. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
17. Dopaminergic drug-induced tics in PARK2-positive Parkinson's disease.
Dafotakis M; Fink GR; Nowak DA
Mov Disord; 2008 Mar; 23(4):628. PubMed ID: 18181204
[No Abstract] [Full Text] [Related]
18. Parkinson's genetics: molecular insights for the new millennium.
Skipper L; Farrer M
Neurotoxicology; 2002 Oct; 23(4-5):503-14. PubMed ID: 12428722
[TBL] [Abstract][Full Text] [Related]
19. [New therapeutic strategy for Parkinson's disease based on pharmacological profiles].
Ogawa N
Nihon Rinsho; 1997 Jan; 55(1):43-51. PubMed ID: 9014422
[TBL] [Abstract][Full Text] [Related]
20. Rare genetic mutations shed light on the pathogenesis of Parkinson disease.
Dawson TM; Dawson VL
J Clin Invest; 2003 Jan; 111(2):145-51. PubMed ID: 12531866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
